未登录

K

Kyla H Thomas

uk research & innovation (ukri)

H指数:32

被引数:3,887

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis

IF5.3

2024-08-073

OA

Peri-operative tobacco cessation interventions: a systematic review and meta-analysis

IF6.9

2023-09-0111

OA

Nicotine receptor partial agonists for smoking cessation

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2023-06-282

OAAI

Nicotine receptor partial agonists for smoking cessation

COCHRANE DATABASE OF SYSTEMATIC REVIEWS

IF9.4

2023-05-0514

OA

Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers

JOURNAL OF PUBLIC HEALTH

IF3.1

2022-10-2915

OAAI

Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas

BMC PUBLIC HEALTH

IF3.6

2022-03-255

OAAI

Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials

比较戒烟药物疗法和电子烟的临床有效性和安全性: 随机对照试验的系统评价和网络荟萃分析

IF5.3

2021-10-1130

OA

Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis

戒烟药物和电子烟: 系统评价、网络荟萃分析和成本效益分析

HEALTH TECHNOLOGY ASSESSMENT

IF4

2021-10-018

OA

Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events

VALUE IN HEALTH

IF6

2021-06-019

OAAI

Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study

IF5.3

2020-12-146

OAAI

Measuring outcomes in trials of interventions for people who self-harm: qualitative study of service users' views

IF3.5

2020-02-1232

OAAI

Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink

HEALTH TECHNOLOGY ASSESSMENT

IF4

2020-02-019

OA

Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study

SCIENTIFIC REPORTS

IF3.9

2019-12-205

OAAI

Evaluation of a primary care-based opioid and pain review service: a mixed-methods evaluation in two GP practices in England

基于初级保健的阿片类药物和疼痛审查服务的评估: 英格兰两种GP实践的混合方法评估

BRITISH JOURNAL OF GENERAL PRACTICE

IF5.2

2019-12-0214

OAAI

Acceptability of a primary care-based opioid and pain review service: a mixed-methods evaluation in England

基于初级保健的阿片类药物和疼痛审查服务的可接受性: 英格兰的混合方法评估

BRITISH JOURNAL OF GENERAL PRACTICE

IF5.2

2019-10-087

OAAI

Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis

LANCET PSYCHIATRY

IF24.8

2019-08-0141

PREAI

Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders

NICOTINE & TOBACCO RESEARCH

IF3

2019-07-1042

OAAI

Evaluating health and well-being outcomes following the South Gloucestershire Pain Review pilot for patients on long-term opioids for chronic non-cancer pain

BRITISH JOURNAL OF GENERAL PRACTICE

IF5.2

2019-06-060

OA

The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records

IF5.3

2018-02-207

OAAI

Association of measures of fetal and childhood growth with non-clinical psychotic symptoms in 12-year-olds: the ALSPAC cohort

BRITISH JOURNAL OF PSYCHIATRY

IF7.6

2018-01-0230

OAAI